PRESAGE BIOSCIENCES, INC.
CIVO, a hand-held microinjection device that delivers multiple drugs directly into tumors and measures single-cell responses to predict treatment efficacy
- Sector
- Medtech
- Headquarters
- SEATTLE, WA
- Founded
- 2008
- Latest Form D
- $8M, Mar 2013
- Total capital
- $17.7M
- Federal grants
- $4.9M
- 3 awards · 2016–2018
- Rank in peer group#157 of 538
- Private capital raised
- $12.7M
- 3 Form D · last Mar 2013
- 164 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 4
- 29 pending · first 2019
- Rank in peer group#125 of 538
Capital timeline
Latest events
- Federal grantHealth and Human S · Phase II · Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma$944K
- Federal grantHealth and Human S · Phase II · Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma$1M
- Federal grantHealth and Human S · Phase II · Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma$3M
- Private capital raisedForm D · SEC · 3rd filing$8M
- Private capital raisedForm D · SEC · 2nd filing$1.6M
- Private capital raisedForm D · SEC · 1st filing$3.2M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 538 peers
Line = medianMedtech · Device
- Federal grants#157 · top 29%
- Granted patents#125 · top 23%
- Linked publications#5 · top 1%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
From SEC Form D filings- Caitlin CameronExecutive Officer, DirectorNamed in SEC Form D filings
- George J. TodaraDirectorNamed in SEC Form D filings
- George J. TodaroDirectorNamed in SEC Form D filings
- James M. OlsonDirectorNamed in SEC Form D filings
- James C. TowneExecutive Officer, DirectorNamed in SEC Form D filings
- Ken K. NussbacherDirectorNamed in SEC Form D filings
Show all 9 people
- Nathan C. CaffoExecutive OfficerNamed in SEC Form D filings
- Scott K. MuranoExecutive OfficerNamed in SEC Form D filings
- Thane KreinerExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 4 granted of 33- PendingPharmaceutical Combinations For The Treatment Of CancerUSPTOApplication 18948242
- PendingPharmaceutical Combinations For The Treatment Of CancerUSPTOApplication 18921886
- GrantedPharmaceutical Combinations For The Treatment Of CancerUSPTOUS 12,171,744
Show all 33 patent records
- Pharmaceutical Combinations For The Treatment Of CancerMar 12, 2026 · Application 18948242Pending
- Pharmaceutical Combinations For The Treatment Of CancerJul 10, 2025 · Application 18921886Pending
- Pharmaceutical Combinations For The Treatment Of CancerDec 24, 2024 · US 12,171,744Granted
- Pharmaceutical Combinations For The Treatment Of CancerOct 22, 2024 · US 12,121,508Granted
- Pharmaceutical Combinations For The Treatment Of CancerOct 5, 2021 · US 11,135,198Granted
- Low-profile Multi-agent Injection System And MethodsJul 29, 2021 · Application 17059994Pending
- Therapeutic Methods And Compositions For Solid DeliveryJun 10, 2021 · Application 17071707Pending
- Methods For Drug DeliveryNov 19, 2019 · US 10,478,157Granted
- Pharmaceutical Combinations For The Treatment Of CancerSep 12, 2019 · Application 16423216Pending
- Therapeutic Methods And Compositions For Solid DeliverySep 13, 2018 · Application 15811636Pending
- Methods For Multiplexed Drug EvaluationJun 29, 2017 · Application 15230235Pending
- Methods For Drug DeliveryDec 25, 2014 · Application 14328132Pending
- Methods For Drug DeliveryOct 30, 2014 · Application 14127763Pending
- Therapeutic Methods And Compositions For Solid DeliveryJun 19, 2014 · Application 14097629Pending
- Methods For Multiplexed Drug EvaluationJun 19, 2014 · Application 14078977Pending
- Extrusion Methods And Devices For Drug DeliveryJun 5, 2014 · Application 13962868Pending
- Methods For Drug DeliveryApplication PCTUS2012062313Pending
- Therapeutic Methods And Compositions For Solid DeliveryApplication PCTUS2011062128Pending
- Low-profile Multi-agent Injection System And MethodsApplication PCTUS2019034912Pending
- Low-profile Multi-agent Injection System And MethodsApplication 62679589Pending
- Pharmaceutical Combinations For The Treatment Of CancerApplication PCTUS2017024618Pending
- Autophagy-inhibiting Compounds And Uses ThereofApplication PCTUS2016034887Pending
- Pharmaceutical Combinations For The Treatment Of CancerApplication 62314356Pending
- Autophagy-inhibiting Compounds And Uses ThereofApplication 62304125Pending
- Autophagy-inhibiting Compounds And Uses ThereofApplication 62168291Pending
- Methods And Devices For Evaluating Drug CandidatesApplication PCTUS2015027163Pending
- Technology Platform To Assess Multiple Cancer Agents Simultaneously Within A Patient's TumorApplication 62149450Pending
- Microinjection Of Agents For Evaluating Systemically Administered TherapiesApplication 62022956Pending
- Methods And Devices For Evaluating Drug CandidatesApplication 61982769Pending
- Methods For Multiplexed Drug EvaluationApplication PCTUS2013069829Pending
- Extrusion Methods And Devices For Drug DeliveryApplication PCTUS2013054206Pending
- Hand-held Device For Drug DeliveryApplication 61815674Pending
- Methods For Multiplexed Drug EvaluationApplication 61725978Pending
Recent research by its founders
- Abstract 2897: A patient-derived fragmented tumor assay for detailed evaluation of drug response in the tumor microenvironment (TME) using scRNAseq20260 cites
- Abstract 5941: Large-scale analysis reveals distinct molecular subtypes in real-world gastric cancer data20260 cites
- Abstract 6187: Elevating bulk sequencing with high-resolution spatial transcriptomics: A paired-data analysis of clinically-relevant spatial niches in CRC and NSCLC20260 cites
Related companies, and why
- Apollo Endosurgery, Inc.Similar federal contract value in Medtech · null in contracts
- Neuraworx Medical Technologies Inc.Similar federal contract value in Medtech · null in contracts
- Augmedics, Inc.Similar federal contract value in Medtech · null in contracts
- IFOCUS IMAGING LLCSimilar federal contract value in Medtech · null in contracts
- Biocure Technology Inc.Similar federal contract value in Medtech · null in contracts
- SpotitEarly, Inc.Similar federal contract value in Medtech · null in contracts
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .